Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation
- 1 September 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (9) , 1935-1944
- https://doi.org/10.1111/j.1538-7836.2005.01523.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Recombinant Activated Factor VII for Acute Intracerebral HemorrhageNew England Journal of Medicine, 2005
- The use of recombinant factor VIIa in the treatment of bleeding disordersBlood, 2004
- Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trialThe Lancet, 2003
- Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patientsTransplantation, 2002
- NovoSeven: mode of action and use in acquired haemophiliaIntensive Care Medicine, 2002
- Factor XIII activity levels in patients with allogeneic haematopoietic stem cell transplantation and acute graft‐versus‐host disease of the gutBritish Journal of Haematology, 2002
- Pharmacokinetics and pharmacodynamics of recombinant factor VIIaClinical Pharmacology & Therapeutics, 1994
- The definition of refractoriness to platelet transfusionsTransfusion Medicine, 1992
- Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing FactorsHepatology, 1984
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974